M. Dilfuza

2 ta ish

Institute of Molecular Biology and Genetics, Cell Signaling, Kyiv, Ukraine

1. 1137 Clinical Characteristics of Uzbek Patients With BRCa Mutated Ovarian Cancer

   M. Dilfuza

   MaqolaOvarian cancer diagnosis and treatmentEuropean Journal of Cancer20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.article.000420

2. 130 Results of the Primary Treatment of Patients With Serous Ovarian Cancer Stage 2 in Relation to Degree of Process Differentiation

   M. Dilfuza

   MaqolaOvarian cancer diagnosis and treatmentEuropean Journal of Cancer20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.article.000435